This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (70)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arch Ophthalmol. 2002;120:835-844.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To identify histopathological changes induced by photodynamic therapy (PDT), 2 human eyes received PDT using verteporfin 1 week before enucleation for large malignant melanoma. Two light doses, 50 and 100 J/cm², were applied to unaffected chorioretinal areas and the optic disc using the standard procedure recommended for patients with age-related macular degeneration (ARMD).

Characteristic hypofluorescence following PDT was documented angiographically 1 week later. The enucleated globes were processed for standard light and electron microscopy.

The PDT-treated areas revealed uniform occlusion of the choriocapillary layer. Vascular endothelial cells were swollen, detached from the basement membrane, and showed rupture and fragmentation to complete degeneration. Capillary lumina were filled with cell debris, fibrin, and thrombocytes. Remaining intact endothelial cells seemed to generate novel vascular channels by recanalization of the obliterated lumen. The overlying retinal pigment epithelium (RPE) showed no significant alteration. Photoreceptors and optic nerve exposed to verteporfin and 100 J/cm² of . . . [Full Text of this Article]

Patients and Methods

Patients

Photodynamic Therapy

Clinical Documentation

Histopathological Evaluation

Results
Angiography

Light Microscopy

Electron Microscopy

Comment
Corresponding author: Ursula Schmidt-Erfurth, MD, Department of Ophthalmology, University Eye Hospital Luebeck, Ratzeburger Allee 160, D-23538 Luebeck, Germany (e-mail: uschmidterfurth@ophtha.mu-luebeck.de).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Same-day administration of verteporfin and ranibizumab 0.5 mg in patients with choroidal neovascularisation due to age-related macular degeneration
Schmidt-Erfurth et al.
Br J Ophthalmol 2008;92:1628-1635.
ABSTRACT | FULL TEXT  

A prospective randomised study on low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration
Odergren et al.
Br J Ophthalmol 2008;92:757-761.
ABSTRACT | FULL TEXT  

Treatment of peripapillary choroidal neovascularisation
Postelmans et al.
Br J Ophthalmol 2008;92:721-722.
FULL TEXT  

Histopathological findings in postmortem eyes after photodynamic therapy for choroidal neovascularisation in age-related macular degeneration: report of two cases
Kang et al.
Br J Ophthalmol 2007;91:1602-1606.
ABSTRACT | FULL TEXT  

Correlation between Focal Macular Electroretinograms and Angiographic Findings after Photodynamic Therapy
Ishikawa et al.
IOVS 2007;48:2254-2259.
ABSTRACT | FULL TEXT  

Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study
Lai et al.
Br J Ophthalmol 2006;90:869-874.
ABSTRACT | FULL TEXT  

Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes.
Tatar et al.
Arch Ophthalmol 2006;124:815-823.
ABSTRACT | FULL TEXT  

Perspectives on verteporfin therapy combined with intravitreal corticosteroids.
Schmidt-Erfurth et al.
Arch Ophthalmol 2006;124:561-563.
FULL TEXT  

Effect of Intravitreal Injection of Ranibizumab in Combination with Verteporfin PDT on Normal Primate Retina and Choroid
Kim et al.
IOVS 2006;47:357-363.
ABSTRACT | FULL TEXT  

Influence of Treatment Parameters on Selectivity of Verteporfin Therapy
Michels et al.
IOVS 2006;47:371-376.
ABSTRACT | FULL TEXT  

Ocular Changes after Photodynamic Therapy
Tzekov et al.
IOVS 2006;47:377-385.
ABSTRACT | FULL TEXT  

Choroidal neovascularisation in pathological myopia: an update in management
Chan et al.
Br J Ophthalmol 2005;89:1522-1528.
ABSTRACT | FULL TEXT  

Choroidal Infarction Following Photodynamic Therapy With Verteporfin
Klais et al.
Arch Ophthalmol 2005;123:1149-1153.
FULL TEXT  

Macular Function after PDT in Myopic Maculopathy: Psychophysical and Electrophysiological Evaluation
Varano et al.
IOVS 2005;46:1453-1462.
ABSTRACT | FULL TEXT  

Application of femtosecond ultrashort pulse laser to photodynamic therapy mediated by indocyanine green
Sawa et al.
Br J Ophthalmol 2004;88:826-831.
ABSTRACT | FULL TEXT  

Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy
Gelisken et al.
Br J Ophthalmol 2004;88:207-211.
ABSTRACT | FULL TEXT  

Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium-Derived Factor
Schmidt-Erfurth et al.
IOVS 2003;44:4473-4480.
ABSTRACT | FULL TEXT  

Macular relocation after photodynamic therapy for recurrent choroidal neovascular membrane: visual results and histopathological findings
Stanga et al.
Br J Ophthalmol 2003;87:975-976.
ABSTRACT | FULL TEXT  

Sequence of Early Vascular Events after Photodynamic Therapy
Michels and Schmidt-Erfurth
IOVS 2003;44:2147-2154.
ABSTRACT | FULL TEXT